FDA NDC Directory · JSON-LD · Markdown

Oxybutynin Chloride Extended Release

NDC 43353-285 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic nameOxybutynin Chloride
Labeler / ManufacturerAphena Pharma Solutions - Tennessee, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA078503
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (5 mg/1)
Marketing started20090301
Package count3

External sources

Source: openFDA. Public-domain (CC0).